PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a ...
The rapid advancement of cell and ex vivo gene therapies demands scalable, efficient, and regulatory-compliant manufacturing solutions. As manufacturing complexities grow, ensuring consistency, ...
NANJING, China--(BUSINESS WIRE)--GenScript ProBio announced today the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu ...
The value of plasmid DNA in today’s biopharma industry cannot be overstated. Plasmid ubiquity can be seen in many therapeutic areas as they are widely used in cell and gene therapy, serve as raw ...
CRISPR-based non-viral gene editing methods have gained popularity among research teams following concerns about the FDA's recent draft guidance on the use of viruses for gene and cell therapy.
ProBio, a CDMO and subsidiary of GenScript Biotech, opened its flagship Cell and Gene Therapy Center of Excellence at the Princeton West Innovation Campus in Hopewell, NJ. The 128,000-sq-ft GMP ...
Circular plasmid DNA has traditionally been used as a stable and efficient vector for gene expression and HDR-mediated gene insertion. These vectors typically carry at least one antibiotic-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results